Endoscopic Stricture Management Device Market Analysis

Endoscopic Stricture Management Device Market Analysis

To get key market trends

  Download Free Sample

Based on the Product, the global market is classified into stents, balloon dilators, bougie dilators, and other products. The stents segment is further segmented into metal stents, plastic stents, and biodegradable stents. The stents segment has asserted its dominance in the global market by securing a significant share and experiencing growth of 6% between 2024 – 2032.
 

• The dominance is propelled by growing innovations in materials used for manufacturing stents to make them more biocompatible and biodegradable. Moreover, stents offer to maintain long-term luminal patency, and reduce the need for repeat interventions compared to balloon dilation, as they provide sustained mechanical support and help prevent stricture recurrence.
   

Based on the application, the endoscopic stricture management device market is classified into esophageal, colonic, pyloric, biliary, and other applications. The esophageal segment held the largest market share of 36.6% in 2023. This dominance can be attributed to high incidence of strictures caused in esophageal region due to gastric diseases such as GERD; esophageal cancer; eosinophilic esophagitis; IBD, and corrosive injuries.
 

Based on the end user, the endoscopic stricture management device market is classified into hospitals, ambulatory surgery centers, and other end users. The hospital segment is expected to reach USD 827.3 million by 2032.
 

• Hospitals dominate the market due to several key factors. Hospitals possess the necessary infrastructure, such as endoscopy suites, specialized endoscopic tools, and skilled staff, to conduct endoscopic procedures for stricture management with safety and efficiency. Moreover, hospitals have access to reimbursement systems and financial backing to facilitate the procurement of endoscopic devices, supplies, and associated services for stricture management.
   

North America region is projected to maintain its lead in the endoscopic stricture management device market, anticipated to reach USD 543.6 million by 2032.
 

• North America has emerged as the dominant force in the market, owing to several factors including rising incidence of diseases such as GERD, gastrointestinal cancer, and IBD resulting into stricture, and widespread awareness regarding early diagnosis and treatment of stricture.
   
• Moreover, easy access to reimbursement and coverage for endoscopic stricture management also helps to drive the demand for endoscopic stricture management devices, thereby supplementing the market growth.